Lori L Wills Gray, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3615 Route 28/66, New Bethlehem, PA 16242 Phone: 814-275-2264 |
News Archive
A study using intricate fiber dissection techniques provides new insights into the deep anatomy of the human brainstem-and helps to define "safe entry zones" for neurosurgeons performing brainstem surgery, according to a special article published in Operative Neurosurgery, a quarterly supplement to Neurosurgery, official journal of the Congress of Neurological Surgeons.
ActiveCare, Inc. and Vista Therapeutics, Inc. announced today a strategic relationship to develop Nano Biosensors for ActiveCare's products and services to be utilized by the elderly. These Biosensors will allow ActiveCare to continuously monitor specific chronic diseases commonly occurring in the elderly and thus preventively predict and avoid acute medical events. "This technology is designed to prolong and improve the quality of life of our senior population," stated James Dalton, President of ActiveCare.
Access Pharmaceuticals, Inc., a biopharmaceutical company specializing in products for cancer and supportive care, announced today it has received initial prescriptions for its lead product, MuGard – an FDA-approved, ready-to-use mucoadhesive oral wound rinse for the management of oral mucositis, a debilitating side effect of radiotherapy and/or chemotherapy.
Merck, known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck's anti-PD-1 therapy, has been approved by the China National Drug Administration for the treatment of adult patients with unresectable or metastatic melanoma following failure of one prior line of therapy.
For the second straight year, Modern Healthcare magazine has named Texas Health Harris Methodist Hospital Southlake (THHMHS) one of the country's 100 Best Places to Work in Healthcare.
› Verified 2 days ago